KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to 0.22%.

  • Resmed's Return on Invested Capital rose 100.0% to 0.22% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.22%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.23% for FY2025, which is 400.0% up from last year.
  • Per Resmed's latest filing, its Return on Invested Capital stood at 0.22% for Q4 2025, which was up 100.0% from 0.22% recorded in Q3 2025.
  • Resmed's 5-year Return on Invested Capital high stood at 0.22% for Q4 2025, and its period low was 0.13% during Q1 2021.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.18% (2022), whereas its average is 0.18%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first tumbled by -600bps in 2021, then soared by 700bps in 2022.
  • Resmed's Return on Invested Capital (Quarter) stood at 0.14% in 2021, then grew by 24bps to 0.17% in 2022, then decreased by -6bps to 0.16% in 2023, then soared by 32bps to 0.22% in 2024, then increased by 4bps to 0.22% in 2025.
  • Its Return on Invested Capital stands at 0.22% for Q4 2025, versus 0.22% for Q3 2025 and 0.22% for Q2 2025.